Gold bars to be exempt from tariffs, White House clarifies
DUBLIN - Investment management firm BlackRock (NYSE:BLK), Inc. has disclosed a 1.65% stake in Mural Oncology plc, according to a regulatory filing published Friday.
The disclosure, made under Rule 8.3 of the Irish Takeover Panel Act, reveals that BlackRock holds 285,844 shares in the oncology-focused company as of July 10, 2025.
The filing shows BlackRock owns and controls 285,829 ordinary shares, representing approximately 1.65% of Mural Oncology’s share capital. The position also includes a small number of cash-settled derivatives amounting to 15 shares.
The disclosure indicates BlackRock transferred out 286 shares as part of its recent dealings with the securities.
The filing was submitted in compliance with Irish takeover regulations, which require disclosure of interests representing 1% or more in companies involved in potential takeover situations.
BlackRock made no disclosure regarding any indemnity arrangements, options, or agreements related to voting rights of Mural Oncology securities.
The investment firm confirmed it holds no short positions in Mural Oncology shares.
The information was provided through a Form 8.3 filing with the Irish Takeover Panel, based on BlackRock’s position as of July 10, 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.